VEW 2022: New dark adaptation modality and other pipeline updates from Heru

Video

Brandon Barber, chief marketing officer at Heru, shares about the company's new dark adaptation modality, which they announced during the 2022 Vision Expo West, as well as other advancements in the pipeline.

Brandon Barber, chief marketing officer for Heru, sat down with Optometry Times® editor, Kassi Jackson, to share about the company's new AMD portfolio expansion, and other items in the pipeline.

Related: Heru expands AMD portfolio with new launch

Key takeaways from the interview:

  • Heru's latest dark adaptation modality. This new technology allows Heru to offer the only AMD portfolio available on the market.
  • The company is providing cloud-based updates for their platform on a weekly and monthly basis to improve customer and patient outcomes.
  • New therapeutic technology is coming out of their research facility in Bascom Palmer Eye Institute, including AR platform adaptations to improve eye defects that lead to limited vision for patients.
  • Barber said that in the next 24 to 36 months, there will be advancements in the areas of AR and VR.
  • These new and coming advancements improve patient experience, as well as will improve the ability for optometrists to "speed more patients through their practice," according to Barber.
Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
© 2024 MJH Life Sciences

All rights reserved.